TB
Trevarx Biomedical, Inc.
SEC filingBiotechnology · Philadelphia, PA
Amount raised$350Ksold at filing
Total offering$750K$400K still open
Investors in the raise6count reported to the SEC
FiledAug 4, 2025first sale Jul 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jean ChoExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.